← Back to Clinical Trials
Recruiting NCT05604391

NCT05604391 The Effect of Free Gingival Graft on Root Closure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05604391
Status Recruiting
Phase
Sponsor Berceste Guler
Condition Gingival Recession
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2022-06-01
Primary Completion 2025-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Free gingival graft placed apicallyFree gingival graft placed coronally

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2022-06-01 with a primary completion date of 2025-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Free gingival graft is a mucogingival surgical technique applied to increase keratinized gingival width and reduce gingival recession. Free gingival graft is one of the most widely used approaches in root closure treatments and in increasing the height of the keratinized gingiva. Evaluation of the effect of the amount of creeping attachment on the root surface caused by the free gingival grafts placed coronally and apical to the mucogingival line on the gingival recession in the mandibular anterior region with keratinized gingival deficiency with gingival recession. Forty patients with gingival recession and insufficient keratinized gingival height will be randomly divided into 2 main groups as free gingival grafts to be placed coronal and apical to the gingival recession.

Eligibility Criteria

Inclusion Criteria: 1. 18-99 years old 2. The patient does not have any systemic disease 3. Presence of at least one tooth with gingival recession in the mandibular anterior region 4. Excessive dentin sensitivity and impaired esthetics associated with recession 5. Identification of the enamel-cementum boundary in the shrinkage region 6. The tooth is alive and there are no irregularities, grooves, caries and restorations in the area to be treated. 7. No periodontal surgical treatment in the relevant areas in the last 24 months 8. Presence of adequate keratinized and attached gingiva in the donor area Exclusion Criteria: 1. Being outside the specified age range 2. Any contraindication for systematic periodontal surgery 3. Failure to define the enamel-cementum boundary in the withdrawal region 4. Presence of caries, restoration, root concavity in the area to be treated 5. Patients who smoke more than 10 cigarettes per day 6. Patients who use drugs that suppress the immune system or impair recovery 7. Patients using drugs that impair bleeding 8. Insufficient keratinized and attached gingiva in the donor area

Contact & Investigator

Central Contact

Berceste Güler

✉ berceste.guler@ksbu.edu.tr

📞 +05059359207

Principal Investigator

Berceste Güler

STUDY DIRECTOR

Kütahya Health Sciences University

Frequently Asked Questions

Who can join the NCT05604391 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05604391 currently recruiting?

Yes, NCT05604391 is actively recruiting participants. Contact the research team at berceste.guler@ksbu.edu.tr for enrollment information.

Where is the NCT05604391 trial being conducted?

This trial is being conducted at Kütahya, Turkey (Türkiye).

Who is sponsoring the NCT05604391 clinical trial?

NCT05604391 is sponsored by Berceste Guler. The principal investigator is Berceste Güler at Kütahya Health Sciences University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology